ArticleBMC gastroenterology2025
Sex-specific adverse effects of lipid accumulation products and cardiometabolic indices on the prevalence of gallstones: insights from the 2017-2020 national health and nutrition examination survey.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Associations between lipid accumulation indices and gallstone prevalence in Chinese elderly: a community-based study in Fuzhou.BMC gastroenterology · 2026Article
- 16S ribosomal ribonucleic acid sequencing reveals bile microbiome features in gallstone disease and their links to blood lipid subtypes.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnthropometric measurements and lipid profiles are associated with the onset of gallstone disease, with these associations exhibiting sex-specific variations. This study investigated the association between the prevalence of gallstones and two anthropometric-lipid markers, namely Lipid Accumulation Products (LAP) and Cardiometabolic Index (CMI), while also assessing the presence of sex disparities.
methodsData from the 2017-2020 National Health and Nutrition Examination Survey (NHANES) were analyzed, including 3,541 participants aged 20 years or older with complete information. Weighted logistic regression, restricted cubic spline modeling, and subgroup analyses were employed to assess the relationship between LAP and CMI and gallstone disease, as well as to investigate potential sex-specific differences. An analysis of the receiver operating characteristic (ROC) curve was performed to assess the prediction accuracy of indices and to determine appropriate cutoff values.
resultsElevated LAP and CMI were significantly correlated with an increased prevalence of gallstone disease among women, whereas no significant association was found in men. For each unit increase in log2-LAP, the multivariable-adjusted odds ratio (OR) for gallstone disease was 1.375 (95% CI: 1.143-1.655). For each 1-point increase in CMI, the multivariable-adjusted OR was 1.408 (95% CI: 1.098-1.806). Quartile analysis demonstrated that higher levels of LAP and CMI were significantly associated with an increased prevalence of gallstones. The associations between CMI, LAP, and the prevalence of gallstones were consistent across all subgroups (p for interaction > 0.05). LAP exhibiting the largest AUC, demonstrating high accuracy in screening for high-risk individuals for gallstone disease, comparable to traditional indices.
conclusionsThe study revealed a positive association between LAP, CMI, and the prevalence of gallstones, observed exclusively among women. The findings suggest that prioritizing the reduction of LAP and CMI is crucial for preventing gallstone disease in women.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.